Homology Study Between Human Drug Metabolizing Enzymes and Intestinal Microbial Metabolizing Enzymes

Weiyi Sun,Yiwen Fang,Yujia Hong,Susan Sheng,Haoyang Xuan,Qi Zhang
DOI: https://doi.org/10.25236/ajmhs.2021.020112
2021-01-01
Abstract:Pharmacology is a very crucial element in the science of human health and diseases. Since this field is mainly involved in the development, testing and availing of human drugs, critical studies are often made in order to ensure that medicine in all markets are safe for each intended purpose of use in humans. It is therefore basically important to understand the relationship between drugs and the human body and by this we mean how pharmaceutical products react within the human body when it comes to fighting diseases and boosting immunity. In order to get this, researchers take into consideration the manner in which human bodies interact with various kinds of medicine. How drugs get absorbed and utilised within the body involves a number of metabolic processes and the process of metabolism is greatly driven by a number of enzymes. Enzymes can either be microsomal with the hepatic enzyme playing the greatest role and often called drug enzyme or non-microsomal enzymes which are quite specific in such a way that they only metabolise drugs with certain structure and content composition. For this study, we shall be looking at how to develop human immunity within the intestinal system considering that there have been a number of viral organisms in the human gut identified by scientists over the last years of research. Microbes evidently determine the level of individual health and wellbeing since how they interact with host cells determines their level of positive or negative effectiveness.
What problem does this paper attempt to address?